Non Small Cell Lung Cancer News and Research

RSS
Non-Small Cell Lung Cancers are a group of lung cancers that are named for the kinds of cells found in the cancer and how the cells look under a microscope. The three main types of non-small cell lung cancer are squamous cell carcinoma, large cell carcinoma, and adenocarcinoma. Non-small cell lung cancer is the most common kind of lung cancer.
Gene therapy may prevent the damaging effects of radiation

Gene therapy may prevent the damaging effects of radiation

Americans' risk of dying from cancer continues to decline

Americans' risk of dying from cancer continues to decline

Tarceva should be tested as front-line therapy for older lung cancer patients

Tarceva should be tested as front-line therapy for older lung cancer patients

Giving patients both chemotherapy and radiation in the beginning of treatment may help cancer patients live longer

Giving patients both chemotherapy and radiation in the beginning of treatment may help cancer patients live longer

Toxicity from chemotherapy in lung cancer patients could help predict treatment efficacy

Toxicity from chemotherapy in lung cancer patients could help predict treatment efficacy

Lorus identifies novel class of lead drug candidates from small molecule anticancer program

Lorus identifies novel class of lead drug candidates from small molecule anticancer program

A preoperative testing strategy may help determine stage of lung cancer more accurately

A preoperative testing strategy may help determine stage of lung cancer more accurately

Mutations in the targets of designer drugs critically influence their effectiveness

Mutations in the targets of designer drugs critically influence their effectiveness

Introgen announces additional broad patent in China

Introgen announces additional broad patent in China

Researchers identify protein called EMP-1 that is present in the tumors of patients who fail to respond to treatment with gefitinib

Researchers identify protein called EMP-1 that is present in the tumors of patients who fail to respond to treatment with gefitinib

Erlotinib increases survival in patients with advanced non-small cell lung cancer

Erlotinib increases survival in patients with advanced non-small cell lung cancer

New clues about the location of genes potentially involved in the most common type of lung cancer

New clues about the location of genes potentially involved in the most common type of lung cancer

Brief course of chemotherapy after surgery should be the new standard of care around the world

Brief course of chemotherapy after surgery should be the new standard of care around the world

Double whammy of chemo plus surgery extends life for lung cancer patients

Double whammy of chemo plus surgery extends life for lung cancer patients

AstraZeneca announces U.S. labeling change to Iressa (gefitinib tablets)

AstraZeneca announces U.S. labeling change to Iressa (gefitinib tablets)

Study examines biomarkers for response to erlotinib in glioma

Study examines biomarkers for response to erlotinib in glioma

Concurrent radiation, chemo, followed by surgery lengthens lung cancer patients' survival

Concurrent radiation, chemo, followed by surgery lengthens lung cancer patients' survival

Study shows the longest reported survival rate for patients with locally advanced lung cancer

Study shows the longest reported survival rate for patients with locally advanced lung cancer

Taxotere shows significant survival benefit in the treatment of advanced gastric cancer

Taxotere shows significant survival benefit in the treatment of advanced gastric cancer

Bevacizumab plus chemo extends survival beyond one year for large group of advanced lung cancer patients

Bevacizumab plus chemo extends survival beyond one year for large group of advanced lung cancer patients